Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) infection is associated with high mortality and has no approved antiviral therapy. We aimed to compare ribavirin and interferon alfa-2a treatment for patients with severe MERS-CoV infection with a supportive therapy only. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Omrani, Ali S, Saad, Mustafa M, Baig, Kamran, Bahloul, Abdelkarim, Abdul-Matin, Mohammed, Alaidaroos, Amal Y, Almakhlafi, Ghaleb A, Albarrak, Mohammed M, Memish, Ziad A, Albarrak, Ali M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106357/
https://www.ncbi.nlm.nih.gov/pubmed/25278221
http://dx.doi.org/10.1016/S1473-3099(14)70920-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106357/
https://www.ncbi.nlm.nih.gov/pubmed/25278221
http://dx.doi.org/10.1016/S1473-3099(14)70920-X

Ejemplares similares